Hospital treatment of psoriasis. A modified anthralin program.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000873:Anthracenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010858:Pigmentation / Q000187:drug effects; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D012535:Scalp / Q000187:drug effects; D012871:Skin Diseases / Q000139:chemically induced; D013194:Staining and Labeling
D000305:Adrenal Cortex Hormones; D000873:Anthracenes; D003879:Dermatologic Agents; D009824:Ointments